2013 - 2016 Involvement of Cytoglobin expressed in hepatic stellate cells in the development of cancer derived from inflamed liver.
2013 - 2016 MicroRNA as a liver fibrosis marker in chronic hepatitis B
2011 - 2014 肝細胞内微量B型肝炎ウイルスの病的意義に関する研究
2011 - 2013 Identification of mechanism of hepatocarcinogenesis by analysi of microRNA
2009 - 2011 データマイニング手法を用いた効果的なC型肝炎治療法に関する研究
2009 - 2011 Analyses of the development of liver cancer and cirrhosis by using cytoglobin-deficient mice
2009 - 2011 Intrahepatic microRNA expression and response to peginterferon-α and ribavirin therapy in patients with chronic hepatitis C
2008 - 2010 Mechanism of hepatocarcinogenesis in patients without infection of hepatitis B and C viruses by molecular biological analysis
2007 - 2008 肝臓病診断用チップ開発に関する研究
2004 - 2007 HBV DNAのヒトゲノムへの組み込みからみた肝発癌機構の再考
2001 - 2003 The relationship between mtDNA injury and hepalocarcinogenesis in chronic hepatitis.
1997 - 2001 オルニチン脱炭酸酵素による細胞増殖および形質転換に関する検討
1997 - 1998 慢性肝疾患(特に肝細胞癌)におけるIRF-1の変化とIFN治療に関する研究
Show all
Papers (411)：
Hanh Vinh Ngo, Thuy Thi Thanh Le, Hieu Ngoc Vu, Hai Hoang, Hiroko Ikenaga, Misako Sato-Matsubara, Sawako Uchida-Kobayashi, Hayato Urushima, Khanh Van Nguyen, Ha Thi Nguyen, et al. Poorly Differentiated Hepatocellular Carcinoma Cells Avoid Apoptosis by Interacting with T Cells via CD40-CD40L Linkage. The American journal of pathology. 2024
Jung Eun Park, Vy H Nguyen, Pei-Chien Tsai, Hidenori Toyoda, Jennifer Leong, Jennifer E Guy, Ming-Lun Yeh, Chung-Feng Huang, Satoshi Yasuda, Hiroshi Abe, et al. Racial and ethnic disparities in untreated patients with hepatitis C virus-related hepatocellular carcinoma but not in those with sustained virologic response. Alimentary pharmacology & therapeutics. 2024
Tomohiro Umezu, Shogo Tanaka, Shoji Kubo, Masaru Enomoto, Akihiro Tamori, Takahiro Ochiya, Y.-H. Taguchi, Masahiko Kuroda, Yoshiki Murakami. Characterization of circulating miRNAs in the treatment of primary liver tumors. Cancer Reports. 2023
Issei Saeki, Yutaka Suehiro, Yurika Yamauchi, Tomomi Hoshida, Norikazu Tanabe, Takashi Oono, Daiki Kawamoto, Tatsuro Nishimura, Toshihiko Matsumoto, Tsuyoshi Ishikawa, et al. Methylated SEPT9 assay-based liquid biopsy as a biomarker in molecular targeted agent-treated hepatocellular carcinoma. Hepatology International. 2023
Fanpu Ji, Eiichi Ogawa, Chung-Feng Huang, Hidenori Toyoda, Yu Jun Wong, Etsuko Iio, Dae Won Jun, Li Liu, Haruki Uojima, Akito Nozaki, et al. REAL-WORLD EFFECTIVENESS AND SAFETY OF INTERFERON-FREE DAAS FOR 14,676 HEPATITIS C (CHC) PATIENTS WITH GENOTYPES 1, 2, 3, 4 AND 6: A MULTINATIONAL STUDY. HEPATOLOGY. 2021. 74. 579A-581A
1989 - 1993 Osaka City University Graduate School, Division of Medicine
1980 - 1986 Osaka City University Medicine
Professional career (2)：
医学博士 (大阪市立大学)
Doctor of Medicine (Osaka City University)
Work history (7)：
2022/04 - 現在 Osaka Metropolitan University Department of Hepatology Professor
2015/04 - 2022/03 Osaka City University Hepatology Hospital professor
2007/04 - 2015/03 Osaka City University Hepatology Associate professor
2005/04 - 2007/03 Osaka City University Hepatology Instructor
2004/04 - 2005/03 Osaka City University General Medicine Instructor
1996/10 - 2004/03 Osaka City University This Department of Internal Medicine Assistant
1998 - 1999 Johns Hopkins University Oncology Center
Show all
Awards (4)：
2004 - 大阪市立大学医学振興協会一般奨励賞
2000 - Liver Forum in Kyoto 研究奨励研究
1996/02 - 大阪市医学会 大阪市医学会市長賞
1992/06 - 日本肝臓学会 研究奨励賞
Association Membership(s) (8)：
THE JAPANESE CANCER ASSOCIATION
, THE JAPAN SOCIETY OF TRANSFUSION MEDICINE AND CELL THERAPY
, JAPAN GASTROENTEROLOGICAL ENDOSCOPY SOCIETY
, THE JAPANESE SOCIETY OF INTERNAL MEDICINE
, JAPANESE SOCIETY OF GASTROENTEROLOGY
, THE JAPAN SOCIETY OF HEPATOLOGY
, 日本輸血細胞治療学会
, アメリカ癌学会
